{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-028128","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.766961+00:00","generated_at":"2026-05-15T01:35:23.318889+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sangamo Therapeutics receives Nasdaq delisting notice; trading to be suspended May 5, 2026","bullets":["Nasdaq staff determined to delist SGMO due to failure to meet minimum bid price requirement.","Trading will be suspended at open on May 5, 2026; company plans to appeal before Nasdaq Hearings Panel.","Common stock approved for quotation on OTCQB Venture Market starting May 5, 2026 under symbol SGMO.","Company previously received two compliance periods but remained non-compliant with bid price rule."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-028128","json":"https://secwatch.observer/filing/0001628280-26-028128.json","markdown":"https://secwatch.observer/filing/0001628280-26-028128.md","text":"https://secwatch.observer/filing/0001628280-26-028128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828026028128/0001628280-26-028128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828026028128/sgmo-20260428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:35:23.318889+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}